ロード中...
Bone Marrow Derived Mesenchymal Stromal Cells from Sickle Cell Disease Patients Display Intact Functionality
Hematopoietic cell transplantation (HCT) is the only cure for sickle cell disease (SCD), but engraftment remains challenging in patients lacking matched donors. Infusion of mesenchymal stromal cells (MSCs) at time of HCT may promote hematopoiesis and ameliorate graft-versus-host disease. Experimenta...
保存先:
| 出版年: | Biol Blood Marrow Transplant |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5390328/ https://ncbi.nlm.nih.gov/pubmed/28132869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.01.081 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|